Immunotherapy for Pancreatic Cancer

 

Related Videos (117)

In this summary, Robert H. Vonderheide, MD, DPhil, offers an overview of recent advances at Penn Medicine in immunological therapy for pancreatic cancer based upon antibodies that activate the patient's immune system to attack the ""scaffolding"" that supports pancreatic malignancies. 

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®